首页> 外文期刊>细胞与分子免疫学:英文版 >CD205-TLR9-IL-12 axis contributes to CpG-induced oversensitive liver injury in HBsAg transgenic mice by promoting the interaction of NKT cells with Kupffer cells
【24h】

CD205-TLR9-IL-12 axis contributes to CpG-induced oversensitive liver injury in HBsAg transgenic mice by promoting the interaction of NKT cells with Kupffer cells

机译:

获取原文
获取原文并翻译 | 示例
       

摘要

Gut-derived bacterial products contribute to liver inflammation and injury during chronic hepatitis B virus infection;however,the underlying mechanisms remain obscure.In this study,hepatitis B surface antigen transgenic(HBs-Tg)mice and their wild-type(WT)control C57BL/6 mice were injected with CpG-oligodeoxynucleotides(ODNs)to mimic the translocation of gut microbial products into the systemic circulation.We found that,compared with the WT mice,the HBs-Tg mice were oversensitive to CpG-ODN-induced liver injury,which was dependent on natural killer T(NKT)cells.CpG-ODN injection enhanced the expression of Fas ligand(FasL)on NKT cells.In addition,hepatocytes from the HBs-Tg mice expressed higher levels of Fas than did those from the WT mice,which was further augmented by CpG-ODN.Interaction of Fas and FasL was involved in the cytotoxicity of NKT cells against hepatocytes in the HBs-Tg mice.Moreover,Kupffer cells in the HBs-Tg mice expressed higher levels of CD205 and produced greater amounts of interleukin(IL)-12 than did those in the WT mice.Finally,the depletion of Kupffer cells,neutralization of IL-12 or specific silencing of CD205 on Kupffer cells significantly inhibited CpG-ODN-induced liver injury and NKT activation in the HBs-Tg mice.Our data suggest that CD205-expressing Kupffer cells respond to CpG-ODNs and subsequently release IL-12 to promote NKT cell activation.Activated NKT cells induce liver damage through the Fas signaling pathway in HBs-Tg mice.

著录项

  • 来源
    《细胞与分子免疫学:英文版》 |2017年第8期|P.675-684|共10页
  • 作者单位

    Anhui Provincial Laboratory of Microbiology and Parasitology Department of Microbiology and Parasitology Anhui Medical University Hefei 230032 China;

    Institute of Immunology and CAS Key Laboratory of Innate Immunity and Chronic Disease School of Life Sciences and Medical Center University of Science and Technology of China Hefei 230027 China;

    Department of Clinical Laboratory First Affiliated Hospital of Anhui Medical University Hefei 230022 China;

    Innovation Center for Cell Biology Hefei National Laboratory for Physical Sciences at Microscale Hefei 230027 China;

    Institute of Immunology and CAS Key Laboratory of Innate Immunity and Chronic Disease School of Life Sciences and Medical Center University of Science and Technology of China Hefei 230027 ChinaInnovation Center for Cell Biology Hefei National Laboratory for Physical Sciences at Microscale Hefei 230027 China;

    Institute of Immunology and CAS Key Laboratory of Innate Immunity and Chronic Disease School of Life Sciences and Medical Center University of Science and Technology of China Hefei 230027 ChinaInnovation Center for Cell Biology Hefei National Laboratory for Physical Sciences at Microscale Hefei 230027 China;

    Institute of Immunology and CAS Key Laboratory of Innate Immunity and Chronic Disease School of Life Sciences and Medical Center University of Science and Technology of China Hefei 230027 ChinaInnovation Center for Cell Biology Hefei National Laboratory for Physical Sciences at Microscale Hefei 230027 China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 肿瘤学;
  • 关键词

    CpG; hepatitis B virus; Kupffer cell; liver injury; NKT cell;

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号